Clinical Characteristics and Treatment of Patients Diagnosed with Pulmonary Arterial Hypertension: A Real-World Study in the USA, Europe and Japan
In this real-world, geographically diverse sample, monotherapy treatment was common, even among patients with advanced disease.
Authors
- Megan Scott (ORCID: https://orcid.org/0000-0003-4166-1908)
- Rogier Klok (ORCID: https://orcid.org/0000-0001-6584-4886)
- R. James White (ORCID: https://orcid.org/0000-0003-1399-5206)
- J. Harley
- Mark Small (ORCID: https://orcid.org/0000-0003-3240-5283)
- Dominik Lautsch (ORCID: https://orcid.org/0000-0003-3803-1817)
- Carmine Dario Vizza (ORCID: https://orcid.org/0000-0002-3540-4983)
Institutions
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- University of Rochester Medical Center (US)
- Adelphi Group (United Kingdom) (GB)
- Sapienza University of Rome (IT)
Publication Details
- Journal
- Advances in Therapy
- Published
- 2024-11-04
- DOI
- https://doi.org/10.1007/s12325-024-03026-1
- Citations
- 3
- Primary Topic
- Pulmonary Hypertension Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.26